Hoatlin:Projects: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
'''Chemical Modulation of the FA/BRCA Pathway.''' We designed a rapid, inexpensive and sensitive cell-free assay to screen for small molecules that modulate the FA/BRCA pathway. We are using this assay to identify potential therapeutic targets and to dissect the activity of the FA proteins within the network of proteins that guard genomic stability.''' | '''Chemical Modulation of the FA/BRCA Pathway.''' We designed a rapid, inexpensive and sensitive cell-free assay to screen for small molecules that modulate the FA/BRCA pathway. We are using this assay to identify potential therapeutic targets and to dissect the activity of the FA proteins within the network of proteins that guard genomic stability.''' | ||
'''Activation of FA proteins by DNA substrates.''' The current understanding of the triggers of activation for the FA/BRCA pathway proteins is incomplete. We are testing DNA binding and DNA structure-specific FA protein activation in cell fre extracts to identify the FA-specific transactions.''' | |||
[[Image:frog.png|300px|thumbnail|left|We use proteins from frog eggs to understand the basics about how the Fanconi proteins are involved in DNA replication and repair.]] | [[Image:frog.png|300px|thumbnail|left|We use proteins from frog eggs to understand the basics about how the Fanconi proteins are involved in DNA replication and repair.]] |
Revision as of 12:09, 4 April 2007
Home Projects Team Papers Contact Us Protocols Collaborations News Reagent Requests secret back door Hoatlin Lab Twitter
The role of the FA proteins at early stages of hematopoiesis. We identified a novel transcriptional repressor (FAZF, for Fanconi Anemia Zinc Finger) that binds to FANCC, one of the Fanconi proteins. We are interested in the functional consequences of this interaction in normal and dysregulated hematopoiesis. Chemical Modulation of the FA/BRCA Pathway. We designed a rapid, inexpensive and sensitive cell-free assay to screen for small molecules that modulate the FA/BRCA pathway. We are using this assay to identify potential therapeutic targets and to dissect the activity of the FA proteins within the network of proteins that guard genomic stability. Activation of FA proteins by DNA substrates. The current understanding of the triggers of activation for the FA/BRCA pathway proteins is incomplete. We are testing DNA binding and DNA structure-specific FA protein activation in cell fre extracts to identify the FA-specific transactions.
|